全文获取类型
收费全文 | 343篇 |
免费 | 19篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 25篇 |
妇产科学 | 4篇 |
基础医学 | 35篇 |
口腔科学 | 9篇 |
临床医学 | 63篇 |
内科学 | 72篇 |
皮肤病学 | 20篇 |
神经病学 | 6篇 |
特种医学 | 59篇 |
外科学 | 13篇 |
综合类 | 26篇 |
预防医学 | 3篇 |
眼科学 | 8篇 |
药学 | 28篇 |
中国医学 | 2篇 |
肿瘤学 | 19篇 |
出版年
2022年 | 4篇 |
2020年 | 2篇 |
2018年 | 6篇 |
2017年 | 3篇 |
2016年 | 8篇 |
2015年 | 6篇 |
2014年 | 8篇 |
2013年 | 10篇 |
2012年 | 7篇 |
2011年 | 8篇 |
2010年 | 11篇 |
2009年 | 22篇 |
2008年 | 9篇 |
2007年 | 33篇 |
2006年 | 12篇 |
2004年 | 9篇 |
2003年 | 6篇 |
2002年 | 7篇 |
2001年 | 9篇 |
2000年 | 2篇 |
1999年 | 5篇 |
1998年 | 16篇 |
1997年 | 19篇 |
1996年 | 24篇 |
1995年 | 12篇 |
1994年 | 24篇 |
1993年 | 5篇 |
1992年 | 2篇 |
1991年 | 6篇 |
1990年 | 7篇 |
1989年 | 9篇 |
1988年 | 7篇 |
1987年 | 5篇 |
1986年 | 8篇 |
1985年 | 6篇 |
1984年 | 4篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 2篇 |
1978年 | 4篇 |
1977年 | 12篇 |
1976年 | 3篇 |
1956年 | 1篇 |
1955年 | 3篇 |
1954年 | 4篇 |
1949年 | 3篇 |
1948年 | 6篇 |
1947年 | 1篇 |
1946年 | 2篇 |
排序方式: 共有394条查询结果,搜索用时 140 毫秒
391.
Background
The World Health Organisation estimates that by 2030 there will be approximately 350 million people with type 2 diabetes. Associated with renal complications, heart disease, stroke and peripheral vascular disease, early identification of patients with undiagnosed type 2 diabetes or those at an increased risk of developing type 2 diabetes is an important challenge. We sought to systematically review and critically assess the conduct and reporting of methods used to develop risk prediction models for predicting the risk of having undiagnosed (prevalent) or future risk of developing (incident) type 2 diabetes in adults.Methods
We conducted a systematic search of PubMed and EMBASE databases to identify studies published before May 2011 that describe the development of models combining two or more variables to predict the risk of prevalent or incident type 2 diabetes. We extracted key information that describes aspects of developing a prediction model including study design, sample size and number of events, outcome definition, risk predictor selection and coding, missing data, model-building strategies and aspects of performance.Results
Thirty-nine studies comprising 43 risk prediction models were included. Seventeen studies (44%) reported the development of models to predict incident type 2 diabetes, whilst 15 studies (38%) described the derivation of models to predict prevalent type 2 diabetes. In nine studies (23%), the number of events per variable was less than ten, whilst in fourteen studies there was insufficient information reported for this measure to be calculated. The number of candidate risk predictors ranged from four to sixty-four, and in seven studies it was unclear how many risk predictors were considered. A method, not recommended to select risk predictors for inclusion in the multivariate model, using statistical significance from univariate screening was carried out in eight studies (21%), whilst the selection procedure was unclear in ten studies (26%). Twenty-one risk prediction models (49%) were developed by categorising all continuous risk predictors. The treatment and handling of missing data were not reported in 16 studies (41%).Conclusions
We found widespread use of poor methods that could jeopardise model development, including univariate pre-screening of variables, categorisation of continuous risk predictors and poor handling of missing data. The use of poor methods affects the reliability of the prediction model and ultimately compromises the accuracy of the probability estimates of having undiagnosed type 2 diabetes or the predicted risk of developing type 2 diabetes. In addition, many studies were characterised by a generally poor level of reporting, with many key details to objectively judge the usefulness of the models often omitted. 相似文献392.
van de Poll MC Derikx JP Buurman WA Peters WH Roelofs HM Wigmore SJ Dejong CH 《World journal of surgery》2007,31(10):2033-2038
Background Liver failure following liver surgery is caused by an insufficient functioning remnant cell mass. This can be due to insufficient
liver volume and can be aggravated by additional cell death during or after surgery. The aim of this study was to elucidate
the causes of hepatocellular injury in patients undergoing liver resection.
Methods Markers of hepatocyte injury (AST, GSTα, and L-FABP) and inflammation (IL-6) were measured in plasma of patients undergoing
liver resection with and without intermittent inflow occlusion. To study the separate involvement of the intestines and the
liver in systemic L-FABP release, arteriovenous concentration differences for L-FABP were measured.
Results During liver manipulation, liver injury markers increased significantly. Arterial plasma levels and transhepatic and transintestinal
concentration gradients of L-FABP indicated that this increase was exclusively due to hepatic and not due to intestinal release.
Intermittent hepatic inflow occlusion, anesthesia, and liver transection did not further enhance arterial L-FABP and GSTα
levels. Hepatocyte injury was followed by an inflammatory response.
Conclusions This study shows that liver manipulation is a leading cause of hepatocyte injury during liver surgery. A potential causal
relation between liver manipulation and systemic inflammation remains to be established; but since the inflammatory response
is apparently initiated early during major abdominal surgery, interventions aimed at reducing postoperative inflammation and
related complications should be started early during surgery or beforehand.
Marcel C. G. van de Poll, Joep P. M. Derikx contributed equally to this work. 相似文献
393.
Bani-Sadr F Goderel I Penalba C Billaud E Doll J Welker Y Cacoub P Pol S Perronne C Carrat F;ANRS HC - Ribavic Study team 《Journal of viral hepatitis》2007,14(9):639-644
The most frequent and the most troublesome adverse effect of interferon plus ribavirin-based therapy is anaemia. The aim of this analysis was to determine the incidence and risk factors of anaemia (Hb < 10 g/dL) in human immunodeficiency virus/hepatitis C virus (HCV)-coinfected patients receiving anti-HCV therapy. We reviewed all cases of anaemia occurring among 416 patients participating in a randomized, controlled 48-week trial comparing peginterferon (peg-IFN) alpha 2b plus ribavirin with interferon alpha-2b plus ribavirin. Univariate and multivariate analyses were used to identify links with antiretroviral treatments, HCV therapy and clinical and laboratory findings. Sixty-one (15.9%) of the 383 patients who received at least one dose of anti-HCV treatment developed anaemia. In multivariate analysis the risk of anaemia was significantly associated with zidovudine (OR, 3.27 95% CI, 1.64-6.54, P = 0.0008) and peg-IFN (OR, 2.35; 95% CI, 1.16-4.57, P = 0.0179). The risk of anaemia was lower in patients with higher baseline haemoglobin levels (OR, 0.35 95% CI, 0.26-0.49, P < 0.0001) and in patients receiving protease inhibitor-based antiretroviral therapy (OR, 0.51 95% CI, 0.30-0.86, P = 0.0114). Zidovudine discontinuation could help to avoid anaemia associated with anti-HCV therapy. 相似文献
394.
抗肿瘤药物的研究:N′,N″-二螺三哌嗪类化合物的合成 总被引:1,自引:0,他引:1
In order to search for new antitumor drugs, sixteen N′, N″-dispirotripiperazine derivatives were synthesized from N′, N″-dispirotripiperazinium dichloride dihydrochloride by substitution, acylation and Mannich reaction. Six compounds were selected for preliminary pharmacological test. The result showed that five compounds possess inhibitory action against carcinoma S37 in rats. The inhibitory activity of compounds Ⅵ and Ⅹ was 55.0% and. 41.9% respectively. 相似文献